THE CLINICAL FEATURES AND LONG-TERM SEQUELAE OF INVASIVE MENINGOCOCCAL DISEASE IN CHILDRENSTEIN-ZAMIR, Chen; SHOOB, Hanna; SOKOLOV, Irina et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 7, pp 777-779, issn 0891-3668, 3 p.Article

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development ProgramO'RYAN, Miguel; STODDARD, Jeffrey; TONEATTO, Daniela et al.Drugs (Basel). 2014, Vol 74, Num 1, pp 15-30, issn 0012-6667, 16 p.Article

Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational studyLOPEZ CASTELBLANCO, Rodrigo; MINJAE LEE; HASBUN, Rodrigo et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 9, pp 813-819, issn 1473-3099, 7 p.Article

Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance dataBIJLSMA, Merijn W; BEKKER, Vincent; BROUWER, Matthijs C et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 9, pp 805-812, issn 1473-3099, 8 p.Article

The first reported case of possible Haemophilus influenzae type b vaccine failure from Kuwait and literature-reviewPUROHIT, Prashant; AL-OBAID, Ina'am Ahmad; OMAR, Nehad Gamal Al-Deen et al.Journal of infection and public health (Print). 2014, Vol 7, Num 2, pp 99-105, issn 1876-0341, 7 p.Article

Vaccine profile of 4CMenB: a four-component Neisseria meningitidis serogroup B vaccineESPOSITO, Susanna; PRINCIPI, Nicola.Expert review of vaccines. 2014, Vol 13, Num 2, pp 193-202, issn 1476-0584, 10 p.Article

Méningo-encéphalite à Bartonella quintana chez un sujet immunocompétent: une observation rare = Bartonella quintana meningoencephalitis in an immunocompetent: Rare caseKOOLI, I; LOUSSAIEF, C; BEN BRAHIM, H et al.Pathologie et biologie. 2014, Vol 62, Num 6, pp 342-344, issn 0369-8114, 3 p.Article

Antibody Persistence After Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in AdolescentsBAXTER, Roger; REISINGER, Keith; BLOCK, Stanley L et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 11, pp 1169-1176, issn 0891-3668, 8 p.Article

A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?MARTIN, Natalie G; SNAPE, Matthew D.Expert review of vaccines. 2013, Vol 12, Num 8, pp 837-858, issn 1476-0584, 22 p.Article

Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT) Given at 12-15 Months of AgeMARSHALL, Gary S; BLATTER, Mark; MARCHANT, Colin et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 6, pp 662-668, issn 0891-3668, 7 p.Article

Comparison of posterior pharyngeal wall and nasopharyngeal swabbing as a means of detecting the carriage of Neisseria meningitidis in adolescentsESPOSITO, S; ZAMPIERO, A; TERRANOVA, L et al.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 9, pp 1129-1133, issn 0934-9723, 5 p.Article

Controlling serogroup B invasive meningococcal disease: the Canadian perspectiveBETTINGER, Julie A; DEEKS, Shelley L; HALPERIN, Scott A et al.Expert review of vaccines. 2013, Vol 12, Num 5, pp 505-517, issn 1476-0584, 13 p.Article

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd ImmunityKRISTIANSEN, Paul A; DIOMANDE, Fabien; CLARK, Thomas A et al.Clinical infectious diseases. 2013, Vol 56, Num 3, pp 354-363, issn 1058-4838, 10 p.Article

Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT; MenHibrix_®): A ReviewPERRY, Caroline M.Drugs (Basel). 2013, Vol 73, Num 7, pp 703-713, issn 0012-6667, 11 p.Article

The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal InitiativeSAFADI, Marco Aurélio P; DE LOS MONTEROS, Luz Elena Espinosa; LOPEZ, Eduardo Luis et al.Expert review of vaccines. 2013, Vol 12, Num 8, pp 903-915, issn 1476-0584, 13 p.Article

The role of Streptococcus intermedius in brain abscessMISHRA, A. K; FOURNIER, P.-E.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 4, pp 477-483, issn 0934-9723, 7 p.Article

Botulisme: toujours des cas en FranceLa Revue Prescrire. 2013, Vol 33, Num 356, issn 0247-7750, p. 465Article

Five-year Antibody Persistence and Safety Following a Booster Dose of Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate VaccineTEJEDOR, Juan Carlos; MERINO, José Manuel; BARRIO, Francisco et al.The Pediatric infectious disease journal. 2012, Vol 31, Num 10, pp 1074-1077, issn 0891-3668, 4 p.Article

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialRICHMOND, Peter C; MARSHALL, Helen S; EIDEN, Joseph et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 8, pp 597-607, issn 1473-3099, 11 p.Article

Endemic Foodborne Botulism among Alaska Native Persons—Alaska, 1947―2007FAGAN, Ryan P; MCLAUGHLIN, Joseph B; CASTRODALE, Louisa J et al.Clinical infectious diseases. 2011, Vol 52, Num 5, pp 585-592, issn 1058-4838, 8 p.Article

Single Nucleotide Polymorphisms in TLR9 Are Highly Associated with Susceptibility to Bacterial Meningitis in ChildrenSANDERS, Marieke S; VAN WELL, Gijs Th. J; OUBURG, Sander et al.Clinical infectious diseases. 2011, Vol 52, Num 4, pp 475-480, issn 1058-4838, 6 p.Article

A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 MonthsDIEZ-DOMINGO, Javier; PLANELLES CANTARINO, M. Victoria; BALDO TORRENTI, Jose M et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 2, pp 148-152, issn 0891-3668, 5 p.Article

Prospective Cohort Study of Disabling Sequelae and Quality of Life in Children With Bacterial Meningitis in Urban SenegalEDMOND, Karen; DIEYE, Yakou; GRIFFITHS, Ulla K et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 11, pp 1023-1029, issn 0891-3668, 7 p.Article

Multicenter, Open-Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in InfancyFINDLOW, Jamie; BORROW, Ray; OSTER, Philipp et al.Clinical infectious diseases. 2010, Vol 51, Num 10, pp 1127-1137, issn 1058-4838, 11 p.Article

Demonstration of Immunologic Memory Using Serogroup C Meningococcal Glycoconjugate VaccineSNAPE, Matthew D; MACLENNAN, Jenny M; LOCKHART, Stephen et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 2, pp 92-97, issn 0891-3668, 6 p.Article